The biggest increase in 2-year survival associated with Medicaid expansion was among patients with stage III disease, with a ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

A s the annual Medicare open enrollment period unfolds, millions of Americans are evaluating their healthcare options for the ...

The Medicaid budget survey for fiscal years 2024 and 2025 revealed state predictions are expecting a decline in Medicaid ...

New research published online-ahead-of-print in Journal of the National Comprehensive Cancer Network found that people with ...

Conservative planning and continued business growth helped Molina keep an ongoing mismatch between payment rates and member ...

The presidential election, loss of higher federal funding, inflationary pressures and other challenges are leaving state ...

The Medicaid rate hike will mitigate headwinds in that line of Molina Healthcare's business, which has seen higher costs ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Medicaid expansion improved 2-year survival rates and access to guideline-concordant treatment for patients with HR-negative ...

Medicaid expansion was associated with a slower decrease in receipt of guideline-concordant treatment, reduced delays in ...

In anticipation of the end of the COVID-19 public health emergency, Congress ended the Medicaid continuous coverage ...